Next-generation Sequencing (NGS) is a parallel processing technique that can establish the sequence of nucleotides in a whole genome with scalability, ultra-high capacity, and fast speed. Furthermore, in the healthcare industry, NGS is gradually being incorporated into medical laboratory research, screening, and disease diagnoses. In personalized medicine, it has been frequently utilized to accelerate the drug research process.Different potential sequencing methods such as RNA sequencing, whole-genome sequencing, and whole-exome and targeted sequencing amongst others are prominently used by researchers to get comprehensive sample analysis. When compared to the traditional Sanger sequencing technology, NGS is less expensive and provides higher throughput for DNA sequencing. The growing automation in the pre-sequencing protocols, post-sequencing protocols, and data analysis is also projected to have a positive impact on the NGS market. The utilization of novel platforms for the development of personalized medicine by medical analysis at a genetic level is also a significant factor, which is expected to enhance demand for NGS over the forecast period.
Get a preview of the latest developments in the Global Next Generation Sequencing Market! Download your FREE sample PDF today and explore key data and trends
Next Generation Sequencing Market Report Highlights
Food & Beverages segment accounted for more than 22.9% in 2022of the industrial type share due to the rising usage of Next Generation Sequencing in bakery and functional food products
Industrial emerged as the largest type segment in 2022 and is estimated to generate revenue of over USD 11.42 billion by 2030
Microorganisms emerged as the largest source segment in 2022 and are estimated to generate revenue over USD 17.47 billion by 2030
North America is projected to witness the fastest growth rate of 6.6% from 2023 to 2030 due to the rising R&D activities across the developed countries coupled with the presence of numerous end-use application manufacturers in the pharmaceuticals, food & beverage, and personal care & cosmetics sector
Pharmaceutical emerged as the largest specialty type segment with a revenue share of 40.6% in 2022, due to the increasing usage of the product in different applications including wound healing, diagnosing diseases, and killing disease-causing bacteria
List of Key Players of Next Generation Sequencing Market
Illumina
Hoffman-La Roche Ltd.
QIAGEN
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Oxford Nanopore Technologies
PierianDx
Genomatix GmbH
DNASTAR, Inc.
Perkin Elmer, Inc.
Eurofins GATC Biotech GmbH
BGI
Gather more insights about the market drivers, restrains and growth of the Next Generation Sequencing Market